Phase II study of rituximab in patients with B-cell lymphoproliferative disorders associated with pharmacologic immunosuppression
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Rituximab (Primary)
- Indications Lymphoproliferative disorders
- Focus Therapeutic Use
- 20 Mar 2012 Biomarkers information updated
- 11 Oct 2005 New trial record.